These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 15075093)
1. Occurrence of a myelodysplastic syndrome (MDS) during first-line 2-chloro-deoxyadenosine (2-CDA) treatment of a low-grade gastrointestinal MALT lymphoma. Case report and review of the literature. Jäger G; Höfler G; Linkesch W; Neumeister P Haematologica; 2004 Apr; 89(4):ECR01. PubMed ID: 15075093 [TBL] [Abstract][Full Text] [Related]
2. Myelodysplastic syndrome with monosomy 5 and/or 7 following therapy with 2-chloro-2'-deoxyadenosine. Van Den Neste E; Louviaux I; Michaux JL; Delannoy A; Michaux L; Hagemeijer A; Scheiff JM; Bosly A; Straetmans N; Ferrant A Br J Haematol; 1999 Apr; 105(1):268-70. PubMed ID: 10233391 [TBL] [Abstract][Full Text] [Related]
3. Long-term safety and activity of cladribine in patients with extranodal B-cell marginal zone lymphoma of the mucosa-associated lymphoid tissue (MALT) lymphoma. Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME; Raderer M Hematol Oncol; 2017 Jun; 35(2):177-186. PubMed ID: 26580149 [TBL] [Abstract][Full Text] [Related]
4. [Secondary myelodysplastic syndrome in a boy with non-Hodgkin's lymphoma]. Hrstková H; Cíhalová V; Pejchlová M; Vrba M Cesk Pediatr; 1993 Nov; 48(11):641-4. PubMed ID: 8299189 [TBL] [Abstract][Full Text] [Related]
5. [Pneumocystis carinii pneumonia during therapy with 2-chlorodeoxyadenosine (2-CDA)]. Haberthür C; Pless M; Tichelli A; Gratwohl A; Speck B; Betticher DC Schweiz Med Wochenschr; 1994 Jan; 124(1-2):73-8. PubMed ID: 7905206 [TBL] [Abstract][Full Text] [Related]
9. Spontaneous remission of 2-chlorodeoxyadenosine (2-CdA)-related secondary myelodysplastic syndrome in a patient with refractory Langerhans cell histiocytosis. Suzuki D; Kobayashi R; Sano H; Kishimoto K; Yasuda K; Nakanishi M; Nagashima T; Kobayashi K Int J Hematol; 2013 Jun; 97(6):782-5. PubMed ID: 23616222 [TBL] [Abstract][Full Text] [Related]
10. Prolonged follow-up after initial therapy with 2-chlorodeoxyadenosine in patients with indolent non-Hodgkin lymphoma: results of Cancer and Leukemia Group B Study 9153. Blum KA; Johnson JL; Niedzwiecki D; Piro LD; Saven A; Peterson BA; Byrd JC; Cheson BD; Cancer; 2006 Dec; 107(12):2817-25. PubMed ID: 17120198 [TBL] [Abstract][Full Text] [Related]
11. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer. Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192 [TBL] [Abstract][Full Text] [Related]
12. Edema of the eyelids and sclera after rituximab infusion for orbital MALT lymphoma. Oribe N; Tanimoto TE; Shimoda K; Hikiji W; Mitsugi K; Takase K; Henzan H; Numata A; Miyamoto T; Fukuda T; Nagafuji K; Harada M Haematologica; 2004 Jun; 89(6 Suppl):EIM14. PubMed ID: 15194556 [No Abstract] [Full Text] [Related]
13. Cladribine in the treatment of low-grade non-Hodgkin's lymphoma. Piro LD Semin Hematol; 1996 Jan; 33(1 Suppl 1):34-9. PubMed ID: 8714615 [No Abstract] [Full Text] [Related]
14. Complex cytogenetics in a case of probably work related MDS/AML. Salamanchuk Z; Jakóbczyk M; Nowak W; Skotnicki AB Leuk Res; 2004 Dec; 28(12):1357-61. PubMed ID: 15475079 [TBL] [Abstract][Full Text] [Related]
15. Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. Zinzani PL; Stefoni V; Musuraca G; Tani M; Alinari L; Gabriele A; Marchi E; Pileri S; Baccarani M Cancer; 2004 May; 100(10):2190-4. PubMed ID: 15139063 [TBL] [Abstract][Full Text] [Related]
16. [Cladribine]. Ogura M Gan To Kagaku Ryoho; 2003 Feb; 30(2):309-17. PubMed ID: 12610885 [TBL] [Abstract][Full Text] [Related]
17. Transformation and progression of Waldenström's macroglobulinemia following cladribine therapy in two cases: natural evolution or iatrogenic causation? Ling S; Joshua DE; Gibson J; Young G; Iland H; Watson G; Ho PJ Am J Hematol; 2006 Feb; 81(2):110-4. PubMed ID: 16432856 [TBL] [Abstract][Full Text] [Related]
18. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2). Ogasawara T; Yasuyama M; Kawauchi K Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101 [TBL] [Abstract][Full Text] [Related]
19. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases. Orazi A Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881 [TBL] [Abstract][Full Text] [Related]